The Northwest Biotherapeutics (OTC: NWBO) stock has had a pretty volatile month so far. However, this past week the stock actually managed to record a gain of 10%.
There was no news about the company last week but considering the gains made by the Northwest stock, it might be a good idea to take a look at development from earlier on this month. On April 1, the company had announced that the development of the production facility at its plant in Sawston, United Kingdom had been completed successfully.
This was a major development for Northwest since the completion of this facility will boost the company’s production capabilities considerably.
After the completion of this production facility, Northwest is also going to be able to move its operations from the cleanroom in London. The higher production capabilities are expected to come as a boost for Northwest and that might be one of the reasons for the new found positivity around the NWBO stock.
Writing for business and finance publishers has become his passion over the last decades after he completed a master’s degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.